Alcohol consumption and plasma concentration of C-reactive protein

Circulation

Volumn 107, Issue 3, 2003, Pages 443-447

  Albert, Michelle A ^a   Glynn, Robert J ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Alcohol; C reactive; Inflammation; Protein

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; HORMONE; PRAVASTATIN; STATINE DERIVATIVE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

ALCOHOL DRINKING; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ETHANOL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; LIPIDS; MALE; MIDDLE AGED; PRAVASTATIN; RISK FACTORS;

EID: 0037469176     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000045669.16499.EC     Document Type: Article

References (28)

1. Rimm EB, Giovannucci EL, Willet WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338:464-468.
2. Gaziano JM, Gaziano TA, Glynn RJ, et al. Light to moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol. 2000;35:96-105.
3. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med. 1995;332:1245-1250.
4. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev. 1993;15:1-24.
5. Doll R, Peto R, Hall E, et al. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ. 1994;309:911-918.
6. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation. 1992;85:910-915.
7. Gaziano JM, Buring JR, Breslow JL, et al. Moderate alcohol intake increased levels of high-density lipoproteins and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829-1834.
8. Ridker PM, Vaughan DE, Stampfer MJ, et al. Association of moderate alcohol consumption and plasma concentration of endogenous tissue type plasminogen activator. JAMA. 1994;272:929-933.
9. Makamal KJ, Jadhav PP, D'Agostino RB, et al. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring Cohort. Circulation. 2001;104:1367-1373.
10. Imhof A, Froelich M, Brenner H, et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001;357:763-767.
11. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
12. Boyle JJ. Association of coronary plaque rupture and atherosclerosis and inflammation. J Pathol. 1997;181:93-99.
13. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
14. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
15. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses, BMJ. 2000;321:199-324.
16. Koenig W, Sund M, Froelich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle aged men: results from MONICA (Monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study. 1984 to 1992. Circulation. 1999;99:237-242.
17. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
18. Albert MA, Staggers J, Chew P, et al. The Pravastatin Inflammation/CRP Evaluation (PRINCE): rationale and design. Am Heart J. 2001;141:893-898.
19. Roberts WL, Molton L, Law TC, et al. Evaluation of nine automated high sensitivity C-reactive protein methods: Implications for clinical and epidemiological application, II. Clin. Chem. 2001;47:418-425.
20. Ridker PM, Hennekens CH, Rifai N, et al. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999;100:713-716.
21. Lowe G, Upton M, Rumley A, et al. Different Effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI, and C-reactive protein: a cross-sectional survey. Thromb Haemost. 2001;86:550-556.
22. Wannamaethee SG, Shaper AG. Taking up regular drinking in middle age: effect on major coronary heart disease events and mortality. Heart. 2002;87:32-36.
23. Constant J. Alcohol, ischemic heart disease, and the French paradox. Clin Cardiol. 1997;20:420-424.
24. Iijima K, Yoshizumi M, Hashimoto M, et al. Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways. Circulation. 2002;105:2404-2410.
25. McCarthy MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes and visceral obesity: down-regulation with essential fatty-acids, ethanol and pentoxiphylline. Med Hypoth. 1999;52:465-477.
26. Ajani UA, Hennekens GH, Spelsberg A, et al. Alcohol consumption and risk of type 2 diabetes mellitus among US male physicians. Arch Intern Med. 2000;160:1025-1030.
27. Ruidavets JB, Ducimetierre P, Arveiler D, et al. Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Commun Health. 2002;56:24-28.
28. Rimm EB, Klatsky A, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is this effect due to beer, wine or spirits? BMJ 1996;312:731-736.